Source:http://linkedlifedata.com/resource/pubmed/id/20718671
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
8
|
| pubmed:dateCreated |
2010-8-19
|
| pubmed:commentsCorrections | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
AIM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Aug
|
| pubmed:issn |
1533-4406
|
| pubmed:author | |
| pubmed:issnType |
Electronic
|
| pubmed:day |
19
|
| pubmed:volume |
363
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
793; author reply 794-5
|
| pubmed:dateRevised |
2010-11-18
|
| pubmed:meshHeading |
pubmed-meshheading:20718671-5-alpha Reductase Inhibitors,
pubmed-meshheading:20718671-Azasteroids,
pubmed-meshheading:20718671-Biopsy,
pubmed-meshheading:20718671-Humans,
pubmed-meshheading:20718671-Male,
pubmed-meshheading:20718671-Prostate,
pubmed-meshheading:20718671-Prostatic Hyperplasia,
pubmed-meshheading:20718671-Prostatic Neoplasms,
pubmed-meshheading:20718671-Risk
|
| pubmed:year |
2010
|
| pubmed:articleTitle |
Dutasteride and prostate cancer.
|
| pubmed:publicationType |
Letter,
Comment
|